GNOM
Global X Genomics & Biotechnology ETF
Price Chart
Latest Quote
$54.92
-0.04 (-0.07%)
Current Price
| Previous Close | $54.96 |
| Open | $54.43 |
| Day High | $55.17 |
| Day Low | $53.92 |
| Volume | 25,290 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.15% |
| Net Assets | $76.76M |
| Expense Ratio | 0.50% |
| Category | Health |
| Fund Family | Global X Funds |
| Net Asset Value | $55.03 |
| Premium/Discount | -0.20% |
| Quarterly Dividend Yield | 1.15% |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $55.90 |
| SMA50 | $50.90 |
| SMA200 | $46.46 |
| RSI | 43.70 |
| ATR | 1.4388 |
| Rel Volume | 0.49 |
Performance History
| Week | -3.05% |
| Month | +9.93% |
| Quarter | +18.97% |
| 6 Months | +13.65% |
| YTD | +20.39% |
| Year | +60.28% |
| 3 Years | +11.96% |
| 5 Years | -42.16% |
| 10 Years | -9.19% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $54.92 | 25,300 |
| 2026-07-16 | $55.10 | 28,200 |
| 2026-07-15 | $55.99 | 22,400 |
| 2026-07-14 | $55.76 | 41,200 |
| 2026-07-13 | $55.61 | 119,100 |
| 2026-07-10 | $56.65 | 33,500 |
| 2026-07-09 | $58.54 | 16,800 |
| 2026-07-08 | $57.34 | 22,600 |
| 2026-07-07 | $58.32 | 23,000 |
| 2026-07-06 | $58.83 | 46,200 |
| 2026-07-02 | $58.40 | 48,000 |
| 2026-07-01 | $57.78 | 51,000 |
| 2026-06-30 | $56.83 | 68,300 |
| 2026-06-29 | $57.12 | 112,500 |
| 2026-06-26 | $56.21 | 52,100 |
| 2026-06-25 | $54.90 | 117,200 |
| 2026-06-24 | $53.72 | 64,300 |
| 2026-06-23 | $52.17 | 55,200 |
| 2026-06-22 | $51.71 | 67,900 |
| 2026-06-18 | $52.02 | 13,700 |
About Global X Genomics & Biotechnology ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.